Skip to content

Effect of Parent-Focused Group Schema Therapy for Adolescents with Anorexia Nervosa:

The Effectiveness of Parent-Focused Group Schema Therapy in Reducing Clinical Symptoms and Improving Parent-Child Relationship Among Adolescents with Anorexia Nervosa

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220714055467N1
Enrollment
18
Registered
2022-09-28
Start date
2022-06-22
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa. Anorexia nervosa

Interventions

Intervention 1: Intervention group: 18 parents of adolescents with Anorexia Nervosa after being clinically assessed and diagnosed, will be randomly allocated to this group. Participants will undergo t

Sponsors

Shiraz University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
11 Years to 18 Years

Inclusion criteria

Inclusion criteria: Parents of adolescents between the ages of 12 and 18 Having at least a caregiver in the home willing to participate in treatment Adolescents must meet DSM-5 criteria for Anorexia Nervosa based on the clinical interview Having body mass index (BMI) between 14 and 18 Being sufficiently medically stable for outpatient treatment Parents must read and speak Persian to at least a sixth-grade level Adolescents on psychotropic medication must be on a stable dose for a period of at least 8 weeks

Exclusion criteria

Exclusion criteria: Adolescents with severe substance abuse, acute psychosis, or at acute risk for suicide Adolescents or caregivers with intellectual disability Experience of participating in Schema Therapy sessions with a trained clinician over the past 12 months before the study begins Report of a current or history of recent or past physical or sexual abuse by a family member

Design outcomes

Primary

MeasureTime frame
The score of the Eating Disorder Examination questionnaire (EDEQ). Timepoint: Measuring the eating disorder in Baseline, Mid-treatment, post-treatment and 3- month follow-up. Method of measurement: Eating Disorder Examination questionnaire (EDEQ).;The score of Parent-Child Interaction Questionnaire-Revised (PACHIQ-R). Timepoint: Measuring the parent-child interaction in Baseline, Mid-treatment, post-treatment and 3- month follow-up. Method of measurement: Parent-Child Interaction Questionnaire-Revised (PACHIQ-R).

Secondary

MeasureTime frame
The score of Difficulties in Emotion Regulation Scale (DERS-16). Timepoint: Measuring the parents' emotion regulation in Baseline, Mid-treatment, Post-treatment and 3-months follow-up. Method of measurement: The Difficulties in Emotion Regulation Scale (DERS-16).;The score of Family Quality of Life Scale (FQOL). Timepoint: Measuring the family's quality of life in Baseline, Mid-treatment, Post-treatment and 3-months follow-up. Method of measurement: Family Quality of Life Scale (FQOL).;The score of Visual Analogue Scale (VAS). Timepoint: The VAS scales will be collected twice per week during baseline period, once a week after each group session, twice per week during the follow-up and once during the follow-up measure. Method of measurement: Visual Analogue Scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Molazadeh

Shiraz University

molazadeh@shirazu.ac.ir+98 21 6621 9473

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026